Civica’s $27.8m New Facility Expands Virginia Drug Hub Vision

Meanwhile, CivicaScript Targets Prostate Cancer With First Product Launch

 
• By Rosalind Rei

Civica has announced a further $27.8m investment to support its plans for insulin and other essential medicines. The news comes shortly after CivicaScript announced its first launch in the form of abiraterone tablets.

Silhouette of construction workers against metal structure and the sky
Civica is building out its capabilities in Virginia • Source: Shutterstock

More from Manufacturing

More from Business